Dr. Hafrun Fridriksdottir

Executive Vice President, Global R&D

Dr. Fridriksdottir became Executive Vice President, Global R&D in November 2017.

From February 2017 to November 2017, she served as Executive Vice President, President of Global Generics R&D, after serving as Senior Vice President and President of Global Generics R&D from 2016.

Prior to joining Teva, from 2015 to 2016, Dr. Fridriksdottir served as Senior Vice President and President of Global Generics R&D in Allergan plc.

From 2002 to 2015, she held positions of increasing responsibility within the Actavis Group, including Senior Vice President, R&D.

From 1997 to 2002, Dr. Fridriksdottir served as Divisional Manager of Development at Omega Pharma, until its merger with Actavis. Dr. Fridriksdottir received an MS degree in pharmacy and a Ph.D. in physical pharmacy from the University of Iceland.

Kåre Schultz

Director and President and Chief Executive Officer

Read more

Richard Daniell

Executive Vice President, European Commercial

Read more

Dr. Sven Dethlefs

Executive Vice President, Global Marketing & Portfolio and International Markets Commercial

Read more

Eric Drapé

Executive Vice President, Global Operations

Read more

Eli Kalif

Executive Vice President, Chief Financial Officer (CFO)

Read more

Brendan O'Grady

Executive Vice President, North America Commercial

Read more

Mark Sabag

Executive Vice President, Chief Human Resources Officer and Global Communications & Brand

Read more

David M. Stark

Executive Vice President, Chief Legal Officer

Read more

Nir Baron

Senior Vice President, Chief Internal Auditor

Read more

Lori Queisser

Sr. Vice President & Global Compliance Officer

Read more